EMEA News

Israeli infusion system specialist Q Core Medical has opened a new European hub in Marseille, France, to capitalise on growing demand for its smart pumps in both hospital and ambulatory care settings. The European HQ will be led by country manager Laurent Schektman, who said that the location was the doorway to the French and European healthcare markets. “France is especially ready for Q Core’s level of infusion system innovation,” he said. “With a growing elderly population, an increased need for infusion and a 5 to 10 percent increase in patients being treated in homecare settings rather than hospitals, France has a real market need for intuitive, easy-to-use and reliable infusion systems.” Q Core’s Sapphire infusion pumps provide lightweight, advanced and intuitive infusion systems that can be used in a range of IV therapies, including pain management, oncology drug delivery, epidural infusion, parenteral nutrition and antibiotic treatments. What’s the impact? France’s healthcare system reflects the global shift of moving patients from hospitals into homecare settings, and has seen a 40 percent year-on-year growth in patients receiving homecare treatments over the past four years. Q Core Director Shaul Eitan said that advanced reimbursement models have done a very good job of creating a relatively lucrative proposition for private companies to participate in the provision of ambulatory homecare in France. With its touch screen and ease of use, the Sapphire infusion pump is already popular with homecare pharmacies. “There are not that many small ambulatory pumps out there, and we have established good market traction since we introduced our first models in 2013,” he said. “We see a lot of interest, not just in France but also in Germany, Holland and the UK.” What’s the trend? While data protection regulations continue to inhibit the role of technologies such as infusion systems in the rise of the Internet of Medical Things (IOMT), Eitan said that gathering data about the use and performance of the pumps has been crucial in their development. Every Sapphire pump requires an annual preventative maintenance service, and Q Core takes the opportunity to pull historical data about its use and analysing it to improve new models. In the short term, enhancements will focus on communications functionality, which will benefit both care providers and patients. On the record “There are a lot of potential solutions for communications into the home space,” said Eitan. “The most critical place for data is on the patient adherence side. On the caregiver side it’s about managing capital cost and maintenance. We’re driving to a place where homecare should be going much faster, getting patients out of hospital and making it cost-effective.”

Health secretary outlines his vision for setting up NHSX, a new unit for digital, data and technology.

Although engaging with the NHS remains a challenge, companies now have more "accessible deployment opportunities", according to the research.

Dame Fiona Caldicott has been appointed as the first statutory national data guardian for health and social care, nearly five years after the role was first created.

The FDA has now cleared the radiology software product Quantib™ ND for distribution in the US.

The new suite of reforms announced also include the development of a new role of chief scientist and a Data, Analytics and Delivery division.

Digital health has often been seen as the future of healthcare, but a recent Rock Health report revealed that women only make up 10.2 percent of digital health CEOs, posing questions about where women fit into this new evolution of healthcare.

Carestream Health announced this morning that it had signed an agreement to sell its healthcare information systems business to Philips. Carestream general manager for healthcare information solutions Ludovic D’Aprea said they “have had global success in providing radiology and enterprise imaging IT systems”, but added: “By becoming part of Philips, the HCIS business will have a greater opportunity to thrive and grow. Both organizations share a commitment to meaningful innovation which is deeply embedded in each company’s culture. "Customers will have access to a broader portfolio of healthcare IT solutions to simplify medical image management, enable effective collaboration and enhance patient care.” Carestream said it would retain its medical imaging, dental and industrial films, non-destructive testing, and precision coating businesses. “Our focus will be on delivering innovation that is life changing—for patients, customers, channel partners, communities and other stakeholders—and we will grow the company for long-term success,” said David Westgate, chairman, president and CEO of Carestream. The companies will continue to operate independently until the close of the sale, which is expected to take place in the second half of the year. Financial terms of the deal were not disclosed.

The initiative is one of ten "Sprint Exemplar Projects" to be funded by UK Research and Innovation. 

A recent article from the HIMSS Insights Global Innovators eBook looked at the impact of a project addressing health inequality in India.